In this model, we observed that naïve OT-I CD8+ T cells, transgenic CD8+ T cells that recognize the SIINFEKL peptide from OVA, adoptively transferred concurrently with tumor cells differentiate into effector CTL by day 15 and developed characteristics of T cell exhaustion by the late end-point day 22. Here, CD8A is linked to neoplasm.